Cargando…
Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958367/ https://www.ncbi.nlm.nih.gov/pubmed/35342045 http://dx.doi.org/10.5045/br.2022.2021183 |
| _version_ | 1784676928404324352 |
|---|---|
| author | Kim, Jin-Hyo Park, Sung-Soo Yoon, Jae-Ho Lee, Sung-Eun Kim, Hee-Je Min, Chang-Ki |
| author_facet | Kim, Jin-Hyo Park, Sung-Soo Yoon, Jae-Ho Lee, Sung-Eun Kim, Hee-Je Min, Chang-Ki |
| author_sort | Kim, Jin-Hyo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8958367 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89583672022-04-01 Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second Kim, Jin-Hyo Park, Sung-Soo Yoon, Jae-Ho Lee, Sung-Eun Kim, Hee-Je Min, Chang-Ki Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022-03-31 2022-03-31 /pmc/articles/PMC8958367/ /pubmed/35342045 http://dx.doi.org/10.5045/br.2022.2021183 Text en © 2022 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Kim, Jin-Hyo Park, Sung-Soo Yoon, Jae-Ho Lee, Sung-Eun Kim, Hee-Je Min, Chang-Ki Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title | Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title_full | Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title_fullStr | Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title_full_unstemmed | Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title_short | Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| title_sort | daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958367/ https://www.ncbi.nlm.nih.gov/pubmed/35342045 http://dx.doi.org/10.5045/br.2022.2021183 |
| work_keys_str_mv | AT kimjinhyo daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond AT parksungsoo daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond AT yoonjaeho daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond AT leesungeun daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond AT kimheeje daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond AT minchangki daratumumabmonotherapyinrelapsedandrefractorymultiplemyelomapatientswithseverelycompromisedforcedexpiratoryvolumeinonesecond |